Trial Profile
Efficacy of efavirenz/emtricitabine/tenofovir versus efavirenz/lamivudine/tenofovir in patients with HIV infection
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 29 Feb 2016
Price :
$35
*
At a glance
- Drugs Efavirenz/emtricitabine/tenofovir-disoproxil-fumarate (Primary) ; Efavirenz/lamivudine/tenofovir disoproxil fumarate
- Indications HIV infections
- Focus Therapeutic Use
- 29 Feb 2016 New trial record